0001140361-15-024569.txt : 20150617 0001140361-15-024569.hdr.sgml : 20150617 20150617155815 ACCESSION NUMBER: 0001140361-15-024569 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150615 FILED AS OF DATE: 20150617 DATE AS OF CHANGE: 20150617 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Havey Adam CENTRAL INDEX KEY: 0001514588 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 15937172 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20853 4 1 doc1.xml FORM 4 X0306 4 2015-06-15 0 0001367644 Emergent BioSolutions Inc. EBS 0001514588 Havey Adam 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 0 1 0 0 EVP, Biodefense Divison Common Stock 2015-06-15 4 M 0 15919 14.67 A 57363 D Common Stock 2015-06-15 4 S 0 15919 31.502 D 41444 D Common Stock 2015-06-15 4 M 0 9773 15.83 A 51217 D Common Stock 2015-06-15 4 S 0 9773 31.665 D 41444 D Common Stock 2015-06-15 4 S 0 10606 31.502 D 30838 D Stock Option 14.67 2015-06-15 4 M 0 15919 0 D 2010-03-11 Common Stock 15919 7960 D Stock Option 15.83 2015-06-15 4 M 0 9773 0 D 2019-03-12 Common Stock 9773 0 D Consists of an option granted under the company's stock incentive plan on March 12, 2013. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.055 to $31.77, inclusive. Consists of an option granted under the company's stock incentive plan on March 13, 2012. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.66 to $31.72, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.03 to $31.76, inclusive. The option vested in three equal installments in March 2014, 2015 and 2016 The option vested in three equal installments in March 2013, 2014 and 2015. /s/ Eric Burt, attorney-in-fact 2015-06-17